In conclusion, GALNT14 “TT” genotype was correlated with T4 stage and associated with poor OS in stage III CRC patients receiving curative resection and adjuvant oxaliplatin-based chemotherapy. This evidence concerns the gene GALNT14 and colorectal carcinoma.